205 related articles for article (PubMed ID: 21053587)
1. Recurrent primary hyperphosphatemic tumoral calcinosis: a case report.
Rangaswamy M; Jayashree K; Saggam P; Vimala MG
Acta Cytol; 2010; 54(5 Suppl):1003-6. PubMed ID: 21053587
[TBL] [Abstract][Full Text] [Related]
2. Recurrent hyperphosphatemic tumoural calcinosis.
Amit S; Agarwal A; Nigam A; Rao YK
BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 23010461
[TBL] [Abstract][Full Text] [Related]
3. Hyperphosphatemic tumoral calcinosis: a 10-year follow-up.
Alves C; Lima R
J Pediatr Endocrinol Metab; 2011; 24(1-2):25-7. PubMed ID: 21528811
[TBL] [Abstract][Full Text] [Related]
4. Hyperphosphatemic tumoral calcinosis.
Mallick S; Ahmad Z; Gupta AK; Mathur SR
BMJ Case Rep; 2013 May; 2013():. PubMed ID: 23645700
[TBL] [Abstract][Full Text] [Related]
5. Primary hyperphosphatemic tumoral calcinosis: a case report.
Huang J; Cao LG; Zhang TR; Li SM; Meng QQ
Osteoporos Int; 2022 Jan; 33(1):309-312. PubMed ID: 34245344
[TBL] [Abstract][Full Text] [Related]
6. [Chronic recurrent multifocal osteomyelitis and tumoral calcinosis--is there an association?].
Maus U; Ihme N; Schroeder S; Andereya S; Ohnsorge JA; Hermanns B; Deutz P; Niedhart C
Klin Padiatr; 2007; 219(5):277-81. PubMed ID: 17763293
[TBL] [Abstract][Full Text] [Related]
7. Recurrent tumoral calcinosis.
Nggada HA; Eni UE; Lawan MA; Pindiga UH; Na'aya HU; Khalil MI
Trop Doct; 2006 Oct; 36(4):240-1. PubMed ID: 17034706
[TBL] [Abstract][Full Text] [Related]
8. Hyperphosphatemic familial tumoral calcinosis secondary to fibroblast growth factor 23 (FGF23) mutation: a report of two affected families and review of the literature.
Chakhtoura M; Ramnitz MS; Khoury N; Nemer G; Shabb N; Abchee A; Berberi A; Hourani M; Collins M; Ichikawa S; El Hajj Fuleihan G
Osteoporos Int; 2018 Sep; 29(9):1987-2009. PubMed ID: 29923062
[TBL] [Abstract][Full Text] [Related]
9. A novel
Zuo Q; Yang W; Liu B; Yan D; Wang Z; Wang H; Deng W; Cao X; Yang J
Front Endocrinol (Lausanne); 2022; 13():1008800. PubMed ID: 36213261
[TBL] [Abstract][Full Text] [Related]
10. Tumoral calcinosis with hyperphosphatemia.
Mahadevan S; Adhisivam B; Kumar CN
Indian J Pediatr; 2005 Oct; 72(10):889-90. PubMed ID: 16272668
[TBL] [Abstract][Full Text] [Related]
11. Complete resolution of tumoral calcinosis after renal transplantation.
Miyamoto M; Shibagaki Y; Kimura K
Urology; 2012 Jun; 79(6):e90-1. PubMed ID: 22516362
[TBL] [Abstract][Full Text] [Related]
12. Massive recurrent tumoral calcinosis: a rare presentation.
Garg B; Sharma V; Khan SA; Rastogi S
Acta Orthop Belg; 2011 Jun; 77(3):410-3. PubMed ID: 21846015
[TBL] [Abstract][Full Text] [Related]
13. Aspiration biopsy cytology of tumoral calcinosis: a case report.
Saleh HA; Baker H
Acta Cytol; 2009; 53(3):323-6. PubMed ID: 19534277
[TBL] [Abstract][Full Text] [Related]
14. A case of familial tumoral calcinosis/hyperostosis-hyperphosphatemia syndrome due to a compound heterozygous mutation in GALNT3 demonstrating new phenotypic features.
Dumitrescu CE; Kelly MH; Khosravi A; Hart TC; Brahim J; White KE; Farrow EG; Nathan MH; Murphey MD; Collins MT
Osteoporos Int; 2009 Jul; 20(7):1273-8. PubMed ID: 18982401
[TBL] [Abstract][Full Text] [Related]
15. Nonfamilial hyperphosphatemic tumoral calcinosis with ulnar neuropathy.
Shetty GM; Murari AS; Shah SV; Dhengle S
Joint Bone Spine; 2009 Mar; 76(2):198-201. PubMed ID: 19073370
[TBL] [Abstract][Full Text] [Related]
16. Cytomorphology of tumoral calcinosis: a case report.
Jassar A; Kumar VK; Kaur K; Bisht A; Mothukuri R
Indian J Pathol Microbiol; 2007 Jul; 50(3):619-21. PubMed ID: 17883163
[TBL] [Abstract][Full Text] [Related]
17. Hyperphosphatemic tumoral calcinosis.
Savaci N; Avunduk MC; Tosun Z; Hoşnuter M
Plast Reconstr Surg; 2000 Jan; 105(1):162-5. PubMed ID: 10626985
[TBL] [Abstract][Full Text] [Related]
18. Tumoral calcinosis, a clinical report of eleven cases.
Noyez JF; Murphree SM; Chen K
Acta Orthop Belg; 1993; 59(3):249-54. PubMed ID: 8237339
[TBL] [Abstract][Full Text] [Related]
19. Familial hyperphosphatemic tumoral calcinosis in an unusual and usual sites and dramatic improvement with the treatment of acetazolamide, sevelamer and topical sodium thiosulfate.
Emecen Sanli M; Kilic A; Aktasoglu E; Inci A; Okur I; Ezgu F; Tumer L
J Pediatr Endocrinol Metab; 2021 Jun; 34(6):813-816. PubMed ID: 33819418
[TBL] [Abstract][Full Text] [Related]
20. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer.
Lammoglia JJ; Mericq V
Horm Res; 2009; 71(3):178-84. PubMed ID: 19188744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
